These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25379643)

  • 1. Synthesis and biological evaluation of liguzinediol mono- and dual ester prodrugs as promising inotropic agents.
    Zhang J; Li W; Wen HM; Zhu HH; Wang TL; Cheng D; Yang KD; Chen YQ
    Molecules; 2014 Nov; 19(11):18057-72. PubMed ID: 25379643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
    Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
    Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold evaluation of liguzinediol analogs as novel cardiotonic agents.
    Liu Z; Li W; Qin K; Wen K; Zhu CJ; Li NG; Bian HM; Wen HM; Chen L
    Pharmazie; 2013 Dec; 68(12):926-32. PubMed ID: 24400437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities.
    Li S; Huang H; Zhang M; Wang W; Xue S; Gao Y; Xie M; Chen K; Liu F; Chen L
    J Cardiovasc Pharmacol; 2017 Apr; 69(4):236-244. PubMed ID: 28134629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel compound liguzinediol exerts positive inotropic effects in isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism.
    Chen L; Xu Y; Li W; Wu H; Luo Z; Li X; Huang F; Young C; Liu Z; Zhou S
    Life Sci; 2012 Oct; 91(11-12):402-408. PubMed ID: 22906633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.
    Zhu HH; Chen YQ; Cheng D; Li W; Wang TL; Wen HM; Chen L; Liu J
    Bioorg Med Chem Lett; 2016 Feb; 26(3):882-884. PubMed ID: 26725025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
    Bandgar BP; Sarangdhar RJ; Ahamed FA; Viswakarma S
    J Med Chem; 2011 Mar; 54(5):1202-10. PubMed ID: 21250699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies.
    Abdel-Azeem AZ; Abdel-Hafez AA; El-Karamany GS; Farag HH
    Bioorg Med Chem; 2009 May; 17(10):3665-70. PubMed ID: 19398345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
    Hansen KT; Faarup P; Bundgaard H
    J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation.
    Park JH; Chang JS; El-Gamal MI; Choi WK; Lee WS; Chung HJ; Kim HI; Cho YJ; Lee BS; Jeon HR; Lee YS; Choi YW; Lee J; Oh CH
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5895-9. PubMed ID: 20728357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfotransferase-catalyzed biotransformation of liguzinediol and comparison of its metabolism in different species using UFLC-QTOF-MS.
    Shen F; Wen HM; Shan CX; Kang A; Dong B; Chai C; Zhang JY; Zhang Q; Li W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():1-7. PubMed ID: 29738966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF
    Hartz RA; Vrudhula VM; Ahuja VT; Grace JE; Lodge NJ; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1360-1363. PubMed ID: 28223020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
    Aboul-Fadl T; Al-Hamad SS; Fouad EA
    Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, bioconversion, and pharmacokinetics evaluation of new ester prodrugs of olmesartan.
    Chang JS; El-Gamal MI; Lee WS; Anbar HS; Chung HJ; Kim HI; Cho YJ; Lee BS; Lee SA; Moon JY; Lee DJ; Jeon HR; Lee J; Choi YW; Oh CH
    Eur J Med Chem; 2011 Sep; 46(9):3564-9. PubMed ID: 21641692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
    Liu ZD; Liu DY; Lu SL; Hider RC
    J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of orally active hypolipidemic agents.
    Bandgar BP; Sarangdhar RJ; Khan F; Mookkan J; Shetty P; Singh G
    J Med Chem; 2011 Aug; 54(16):5915-26. PubMed ID: 21770455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotonic agents. 7. Prodrug derivatives of 4-ethyl-1,3-dihydro- 5-[4-(2-methyl-1H-imidazol-1-yl)benzoyl]-2H-imidazol-2-one.
    Shaw KJ; Erhardt PW; Hagedorn AA; Pease CA; Ingebretsen WR; Wiggins JR
    J Med Chem; 1992 Apr; 35(7):1267-72. PubMed ID: 1560439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.